Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective

por Lopes David, Bruna Bianca, Nazareth Aguiar Junior, Pedro, Costa e Silva, Matheus, Dienstmann, Rodrigo, Gil Ferreira, Carlos, Serrano, César
Publicado 2023